Standout Papers

Dapagliflozin maintains glycaemic control while reducing weight and body fat mass over 2 years in ... 2013 2026 2017 2021 376
  1. Dapagliflozin maintains glycaemic control while reducing weight and body fat mass over 2 years in patients with type 2 diabetes mellitus inadequately controlled on metformin (2013)
    Jan Bolinder, Östen Ljunggren et al. Diabetes Obesity and Metabolism

Immediate Impact

1 from Science/Nature 63 standout
Sub-graph 1 of 22

Citing Papers

Medications for Obesity
2024 Standout
Obesity Management in Adults
2023 Standout
2 intermediate papers

Works of AM Langkilde being referenced

Changes in weight loss‐related quality of life among type 2 diabetes mellitus patients treated with dapagliflozin
2014
Dapagliflozin maintains glycaemic control while reducing weight and body fat mass over 2 years in patients with type 2 diabetes mellitus inadequately controlled on metformin
2013 Standout

Author Peers

Author Last Decade Papers Cites
AM Langkilde 474 216 323 11 591
Andrew Vick 227 142 223 17 594
Tomomi Ishihara 359 227 358 13 709
Lucília M. A. Lessa 314 132 255 15 606
H. Steinberg 267 91 159 10 659
Louise Lundby‐Christensen 330 222 153 20 541
Suat Akgün 226 114 221 21 660
Ehtasham Ahmad 330 123 232 19 731
W. Marz 244 134 102 11 716
Charles F. Shaefer 348 123 126 13 658
Aastha Chawla 350 96 148 11 736

All Works

Loading papers...

Rankless by CCL
2026